December 2011 Newsletter

Workshop Envisions Projects to Facilitate Work in the Information Ecosystem

An enthusiastic and IES vocal group of 38 Pistoia Alliance members and non-members met in Hannover, Germany on 10 October 2011 to discuss the "information ecosystem" in biomedical and pharmaceutical research. The objective was to define some tangible projects that would contribute to the ecosystem and that could be undertaken by the Pistoia Alliance. Themes included defining and publishing common use cases; harmonizing processes to facilitate collaboration between life science companies and CROs; and identifying, signposting, and perhaps "certifying" standards within the industry. The group continues to participate in regular teleconferences and has built a portfolio of topics that may be launched as official Pistoia working groups. Anyone is welcome to join ongoing discussions.   

 

 

Visit information ecosystem Basecamp page (login required) » 

Email the executive director for the latest information »  

Michael Braxenthaler Appointed New Pistoia Alliance President

The Pistoia Alliance Board of Directors appointed Michael Braxenthaler, global head of strategic alliances in pharma research and early development informatics at Roche, as president of the Pistoia Alliance in November 2011. Michael takes over from Pistoia Alliance co-founder Nick Lynch, who has moved into Michael's prior role as the Alliance external liaison. "I can't say enough about Martineverything Nick has done to build the Alliance's portfolio and credibility in our industry," said Michael. "He's left me some big shoes to fill, but I'm committed to driving the Alliance's portfolio, particularly in the increasingly complex areas of biomedical and biopharmaceutical informatics."

 

 

Read more about the Operational Team »

Updates from the Working Groups

Sequence Services 

Ten proposals were received in response to the Phase 2 RFP. Three proposals demonstrated deep knowledge and experience in bioinformatics, strong customer focus and alignment to the RFP, ability and experience in providing extensible cloud services, and innovative approaches to the problems presented in the RFP. In December, the five participating pharma companies in the sequence services working group (GSK, BMS, AZ, Lundbeck, and Roche) signed shared-risk funding agreements to develop the proposals submitted by

  • Constellation/GeneStack
  • Eagle Genomics/Cycle Computing
  • Hewlett-Packard Company

We look forward to seeing the outputs from these companies at the Pistoia Alliance Conference and Members' Meeting in April.

 

Read more about the winning proposals »

 

Sequence Squeeze

 

Two entries are making a bid for the US$15,000 prize for developing the best new algorithm for compressing next-generation sequencing data. Check out the leaderboard on the Sequence Squeeze website to see where things stand so far.

 

In our last newsletter, we mentioned that there were four judges for this competition. And while we correctly identified the fourth judge's affiliation (the Broad Institute), we named the wrong individual. Tim Fennel, assistant director for sequencing pipeline informatics at the Broad, will serve as the fourth judge on a panel that also includes representatives from BGI, the Wellcome Trust Sanger Institute, and Pistoia.

 

Learn more about Sequence Squeeze » 

 


 

SESL

 

Ian Harrow gave a well-received talk at Bio-ITWorld European Conference and Expo in October that raised the possibility of transferring the learnings from the SESLpilot to the IMI Open PHACTS project. Two papers further detailing the results of the SESL effort are being developed for publication.

  

View Ian Harrow's Bio-ITWorld presentation »     

Access SESL public demonstrator »  

Read more about SESL »  

 


 

Vocabulary Services 

 

A paper by the vocabulary services team titled "Empowering Industrial Research with Shared Biomedical Vocabularies" was recently published in Drug Discovery Today. This paper lays out the need for shared vocabulary services and posits a way forward. But for the Pistoia Alliance to sponsor some projects, we need support and funding.

 

Learn more about VSI »   

Download the Drug Discovery Today paper »   

Email the Executive Director to get involved in VSI »   

New Pistoia Alliance Working Groups

Several new projects are getting underway.

  • NMR Automatic Structure Verification: This working group will provide a service that vendors can use to verify the ability of their software to automatically verify chemical structures from NMR spectra. First steps are to identify a project data curator and an appropriate platform for sharing data. The project is anticipated to run through September 2012. (John Hollerton, GSK, project lead)
  • Assets Management and Assets Sharing: This project aims to identify and standardize  appropriate business processes and methods for managing samples and sharing associated data assets with external groups. The project is anticipated to run through November 2012. First steps are to identify and prioritize standards associated with asset management.
  • Secondary Pharmacology Discussion Group: The aim of this working group is to reduce later-stage compound attrition by sharing information precompetitively. The group will produce a list of targets and technologies used in early secondary pharmacology and case studies highlighting the value of these approaches. The project is anticipated to run through December 2012.

Several exploratory working groups are also being formed to explore the feasibility of several other project ideas, including

  • Developing a "disease explorer" for navigating various layers of disease information
  • Identifying, signposting, and certifying standards relevant to Pistoia members
  • Defining standards for exchanging biomarkers
  • Determining standards for improving collaboration around the management of screening data and exchanging this type of data with CROs
  • Creating a canonical model for large molecules
As each group launches it will hold a teleconference and webinar to present its purpose and engage in discussion about how to proceed. The first of these will be on the biomarker topic. See the list of upcoming events for more details.

 

Get involved by emailing the executive director »    

Find out how to join the Pistoia Alliance »

New Members

Welcome to core members Johnson & Johnson and Unilever and contributing members Connected Discovery, Fulcrum Direct, The Hyve, Peter Boogaard, and Ian Harrow Consulting Ltd. Alliance membership currently stands at 60.

 

See full list of Pistoia Alliance members »    

Learn about joining the Pistoia Alliance »    

More Articles...

Page 1 of 2

Start
Prev
1

Newsletter Signup

Stay up to date on the latest news and announcements from the Pistoia Alliance!

Join Our Mailing List
Enter Your Email:
For Email Marketing you can trust

Join the Alliance!

If your organization would like to become a member of the Pistoia Alliance or to upgrade your current membership,

Contact us!